Prostate cancer decisions — 2022

The Board denied service connection for the claimed conditions as due to herbicide exposure, finding that there was no evidence of such exposure during active duty.

The Veteran's appeal for increased ratings for prostate cancer and depressive disorder was denied. The Veteran also received a grant of TDIU.

The Veteran's prostate cancer status post brachytherapy is remanded for further evaluation due to a challenge to the competency of the February 2016 VA examiner.

The Board has decided to remand the case due to inadequate reasons or bases for its denial decision, including VA's failure to notify the appellant of a private physician's medical records. The matter is now being returned to the Board for further consideration.

Service connection is granted for residuals of prostate cancer and heart condition (including an old inferior myocardial infarction).,The Veteran's kidney cancer claim is remanded as additional medical records are needed to determine the relationship between his service-connected conditions and his current health issues.

The Board has dismissed the Veteran's appeals for service connection on all issues related to his claimed conditions, as the appellant withdrew these claims through their authorized representative.

The Board has decided that additional development is needed to verify the Veteran's claimed exposure to herbicides while aboard the USS Raleigh, and thus the cases are being remanded for further action.

The Veteran's service connection for prostate cancer is granted due to presumed exposure to herbicide agents during service in Thailand. The issue of an initial compensable rating prior to May 16, 2018, and an increased rating thereafter for bilateral hearing loss is remanded.

The Veteran's prostate cancer is presumed to be causally related to his in-service herbicide exposure at Ubon RTAFB and Nakhon Phanom RTAFB in Thailand, and the claim for service connection is granted.

The Veteran's prostate cancer and bilateral hearing loss ratings are being remanded for additional development, including a new examination to assess the current severity of his service-connected disabilities.

The Board has granted reopening of the claims for service connection for heart disease, diabetes mellitus, prostate cancer, anemia, and sleep apnea. However, the criteria for these conditions are not met as they are not related to service.

The Veteran's prostate cancer and its residuals, including urinary incontinence and erectile dysfunction, are rated at 100% from February 22, 2011, through August 22, 2011.,Beginning August 23, 2011, the Veteran is granted a 20% rating for his service-connected erectile dysfunction.

The Veteran's other specified anxiety disorder is currently rated at 30 percent, which is the maximum rating available under the General Rating Formula for Mental Disorders.,The Veteran's hypertension has been rated as 10 percent disabling since July 27, 2020.

The reduction from a 100% rating to a 30% rating for prostate cancer residuals is granted, but the Veteran's claim for an increased rating remains pending.

The Board has remanded the Veteran's claim for a new VA examination to determine the current severity of his service-connected prostate cancer, status post prostatectomy. The Veteran was given multiple opportunities for an examination but did not attend.

The Board has decided to remand the claims for service connection for heart disability, prostate cancer, and Dupuytren's disease due to a need to determine if the Veteran was exposed to Agent Orange while serving on the U.S.S. Constellation.

The Veteran's service connection claims for prostate cancer and a chronic lumbar spine disability have been granted. The claim for right ear hearing loss is remanded, as well as the initial compensable rating claim for left ear hearing loss.

The Board has remanded the case due to inadequate medical opinion regarding the relationship between the Veteran's prostate cancer and his exposure to contaminated water at Camp Lejeune. The appellant seeks service connection for the cause of her husband's death, which is related to prostate cancer.

The Board denied service connection for prostate cancer and bladder cancer, finding that the evidence did not support a link between these conditions and active service, including exposure to ionizing radiation.

The Board has remanded the cases due to insufficient verification of the Veteran's exposure to herbicide agents during service, specifically near the DMZ in Korea. The cases will be re-adjudicated after further investigation.